Your browser doesn't support javascript.
Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series.
Abolmaali, Meysam; Heidari, Matineh; Zeinali, Marjan; Moghaddam, Parichehr; Ramezani Ghamsari, Mona; Jamshidi Makiani, Mahin; Mirzaasgari, Zahra.
  • Abolmaali M; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
  • Heidari M; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Zeinali M; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Moghaddam P; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Ramezani Ghamsari M; Clinical Research Development Unit of Shahid Rajaei, Educational & Medical Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Jamshidi Makiani M; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Mirzaasgari Z; Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
J Clin Neurosci ; 83: 119-122, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1033546
ABSTRACT
The global SARS-CoV-2 pandemic posed an unprecedented challenge to almost all fields of medicine and Neurology is not an exception. Collecting information about its complications and related conditions will help clinicians to become more confident in managing this disease. Guillain-Barre Syndrome (GBS) is mostly described as a post-infectious phenomenon and its occurrence during acute phase of illness is of interest. GBS has recently been reported during the active phase of COVID-19 for the first time. Severity and fast progression of GBS associated with COVID-19 have also been shown in recent studies. Here we report three cases of GBS during the active phase of COVID-19 with severe symptoms and fast progression to quadriplegia and facial diplegia over 2 days, which led to death in one case due to severe autonomic dysfunction. We suggest SARS-CoV-2 might be associated with rather a severe, rapidly progressive and life-threatening phenotype of GBS.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: J Clin Neurosci Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: J.jocn.2020.11.013

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: J Clin Neurosci Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: J.jocn.2020.11.013